期刊文献+

癌症患者静脉血栓栓塞症的预防进展 被引量:5

下载PDF
导出
摘要 静脉血栓栓塞症(VTE)是癌症患者最常见的并发症之一,现已发现癌症患者VTE的风险比非癌症患者增加4倍之多[1]。已发生VTE癌症患者的存活率明显低于未发生VTE的癌症患者[2]。本文对癌症患者的VTE风险、可能的发病机制以及有效的预防措施进行综述。1 VTE的风险VTE的风险依癌症的类型不同而不同,胰腺癌具有最高的VTE风险。
出处 《实用心脑肺血管病杂志》 2012年第9期1431-1432,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
  • 相关文献

参考文献21

  • 1Blom JW,Doggen CJ,Osanto S,et al.Malignancies,prothrombotic mutations,and the risk of venous thrombosis[J].JAMA,2005,293(6):715-722. 被引量:1
  • 2Chew HK,Wun T,Harvey D,et al.Incidence of venous thromboembolism and its effect on survival among patients with common cancers[J].Arch Intern Med.2006,166(4):458-464. 被引量:1
  • 3Stein PD,Matta F.Acute pulmonary embolism[J].Curr Probl Cardiol,2010,35(7):314-376. 被引量:1
  • 4Bergqvist D.Venous thromboembolism and cancer:prevention of VTE[J].Thromb Res,2001,102(6):V209-V213. 被引量:1
  • 5Fisher B,Costantino JP,Wickerham DL,et al.Tamoxifen for the prevention of breast cancer:current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study[J].J Natl Cancer Inst,2005,97(22):1652-1662. 被引量:1
  • 6Pritchard KI,Paterson AH,Paul NA,et al.Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer.National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group[J].J Clin Oncol,1996,14(10):2731-2737. 被引量:1
  • 7Thürlimann B,Keshaviah A,Coates AS,et al.Breast International Group(BIG) 1-98 Collaborative Group.A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer[J].N Engl J Med,2005,353(26):2747-2757. 被引量:1
  • 8Johnson DH,Fehrenbacher L,Novotny WF,et al.Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic nonsmall-cell lung cancer[J].J Clin Oncol,2004,22(11):2184-2191. 被引量:1
  • 9ElAccaoui RN,Shamseddeen WA,Taher AT.Thalidomide and thrombosis.A meta-analysis[J].Thromb Haemost,2007,97(6):1031-1036. 被引量:1
  • 10Nalluri SR,Chu D,Keresztes R,et al.Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients:a meta-analysis[J].JAMA,2008,300(19):2277-2285. 被引量:1

二级参考文献47

共引文献16

同被引文献41

  • 1邱贵兴,王炜.骨科领域静脉血栓栓塞症的预防[J].中国血管外科杂志(电子版),2011,3(1):9-11. 被引量:21
  • 2陈伟海,徐晓玉,胡益勇,王淑美,陈刚.阿魏酸钠对小鼠H22肝癌生长的抑制作用及其机制研究[J].北京中医药大学学报,2006,29(10):690-693. 被引量:15
  • 3Lee AY. Epidemiology and management of venous thromboembolism in patients with cancer [J]. Thromb Res, 2003, 110 (4) : 167 -172. 被引量:1
  • 4Alizadeh K, Hyman N. Venous thromboembolism prophylaxis in colorec- tal surgery [J]. Surg Technol Int, 2005, 14:165 -170. 被引量:1
  • 5Bergqvist D. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients [ J ]. Dis Colon Rectum, 2006, 49 (10) : 1620 -1628. 被引量:1
  • 6Kum CK, Sire EK, Ngoi SS. Deep vein thrombosis complicating colorec- tal surgery in the Chinese in Singapore [J]. Ann Acad Med Singapore, 1993, 22 (6): 895-897. 被引量:1
  • 7Ho YH, Seow- Choen F, Leong A, et al. Randomized, controlled trial of low roolecular weight heparin vs. no deep vein thrombosis prophy- laxis for major colon and rectal surgery in Asian patients [J]. Dis Co- lon Rectum, 1999, 42 (2): 196-202. 被引量:1
  • 8Low S, Chin MC, Ma S, et al. Rationale for redefining obesity in A- sians [J]. Ann Aead Med Singapore, 2009, 38 (1): 66 -69. 被引量:1
  • 9Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembdism: American CoUege of Chest Physicians Evidence - Based Clinical Practice Guidelines (Sth Edition) [J]. Chest, 2008, 133 (6 Suppl) : 381S-453S. 被引量:1
  • 10Colditz GA, Tnden RL, Oster G. Rates of vennus thrombosis after gen- eral surgery: combined results of randomized clinical trials [ J]. Lan- cet, 1986, 2 (8499) : 143 -146. 被引量:1

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部